Kathy Bates Regrets For Not Making Her Cancer Battle Public

Oscar-winning actress Kathy Bates has revealed that she now wishes she would have made her ovarian cancer battle public so that she could have aided others by creating awareness.

The 'Revolutionary Road' star said that she could not bring herself to confront her fears in public during the ongoing fight with the disease.

Ovarian Cancer | Cancer in the Ovaries - Causes, Symptoms, Treatment & Prevention
Ovarian cancer affects both the ovaries and is referred to as the 'silent killer' as the symptoms go unnoticed until the disease advances.

"I shook all afternoon after I had gotten the news and I was going for more tests. I was sitting in my hospital gown and someone recognised me... I was like, 'I don't wanna talk about that now'," Contactmusic quoted her as saying.

"But, had I to do it over again I think I would have been more public about it... I think it may have helped more people because it's such a difficult disease to diagnose early; I was very, very lucky," she added.

The two-time Golden Globe-winner, who is now a spokeswoman for Ovarian Cancer Foundation, further added that she wanted to help other women cite the cancer symptoms as early as possible.

Quiz on Cancer
Cancer, is the second most leading cause of death worldwide. Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Take this quiz on and test how much you know about cancer.

She said: "(I want) to spread awareness about your body and trying to stay in tune with your body and get tested when you can for anything that doesn't seem right. I have a PSA out that talks about the different symptoms you can be aware of."

Source-ANI
SK

Talcum Powder may Raise Cancer Risk in Women
It might come handy while freshening faces, but according to a new shocking research, women who use talcum powder every day are 40 per cent more likely to develop ovarian cancer.

Combined Molecular-targeted and Hormonal Therapies Offer Promise in Treating Ovarian Cancer
A combination of molecular-targeted therapy and hormonal therapy may be the most promising